EU drugs agency recommends suspension of tetrazepam
LONDON, April 29
LONDON, April 29 (Reuters) - EU drugs regulators have recommended suspending use of all tetrazepam-containing medicines following reports of serious skin reactions, the European Medicines Agency said on Monday.
Tetrazepam belong to a class of drugs known as benzodiazepines and is used in several European Union countries to treat conditions such as back and neck pain and spasticity.
(Reporting by Kate Kelland, editing by Ben Hirschler)
- Target says data from 40 million cards stolen in holiday period
- UPDATE 3-Saab wins Brazil jet deal after NSA spying sours Boeing bid
- Special Report: Why Ukraine spurned the EU and embraced Russia
- Facebook, Zuckerberg, banks must face IPO lawsuit: judge
- Zuckerberg to sell Facebook shares worth about $2.3 billion